Utility of FDG-PET Imaging for Risk Stratification of Pancreatic Neuroendocrine Tumors in MEN1.

Autor: Kornaczewski Jackson, Elena R, Pointon, Owen P, Bohmer, Robert, Burgess, John R
Zdroj: The Journal of Clinical Endocrinology & Metabolism; June 2017, Vol. 102 Issue: 6 p1926-1933, 8p
Abstrakt: Patients with multiple endocrine neoplasia type 1 (MEN1) are at high risk of malignant pancreatic neuroendocrine tumors (pNETs). Structural imaging is typically used to screen for pNETs but is suboptimal for stratifying malignant potential.
Databáze: Supplemental Index